Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ADGM
ADGM logo

ADGM Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Adagio Medical Holdings Inc (ADGM) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
0.680
1 Day change
-2.86%
52 Week Range
2.580
Analysis Updated At
2026/06/11
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

ADGM is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to allocate. The stock has positive analyst coverage and strong hedge fund accumulation, but the technical setup is still mixed and there is no recent news or financial quarter data to confirm improving fundamentals. Given the user's impatient profile and preference not to wait for a perfect entry, I would still not call this a buy yet because the current signal quality is not strong enough; the best direct call from this data is to hold and wait for clearer confirmation.

Technical Analysis

ADGM closed at 0.794 after rising from 0.7537, which shows short-term strength. MACD histogram is positive and expanding, indicating improving momentum. However, RSI_6 at 53.334 is neutral, so the move is not overextended. The moving averages remain bearish with SMA_200 > SMA_20 > SMA_5, which means the broader trend is still weak despite the recent bounce. Price is trading just above pivot (0.757) and below resistance R1 (0.801), so it is near a short-term decision area rather than in a confirmed breakout trend. Overall, the chart suggests early recovery, but not a clean long-term uptrend yet.

Positive Catalysts

  • Hedge funds are reported to be buying aggressively, with buying amount up 1972.62% over the last quarter. The stock also showed a positive market reaction, and similar-pattern analysis suggests modest upside probabilities over the next day, week, and month.

Neutral/Negative Catalysts

  • No news in the past week, so there is no fresh event-driven catalyst. The moving averages remain bearish, showing the larger trend is still not established. RSI is neutral rather than strongly bullish. Insider trading is neutral with no significant activity. No recent congress trading data is available. Financial snapshot data was unavailable, limiting confidence in the fundamental picture.

Financial Performance

Latest quarter financial data was not available due to an error in the provided snapshot, so recent revenue and growth trends cannot be verified. Because the latest quarter season is missing, there is no reliable quarterly financial read to support a long-term buy decision from fundamentals.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent analyst sentiment is positive: Lucid Capital initiated coverage on 2026-06-03 with a Buy rating and $3 target, and Piper Sandler initiated on 2026-04-14 with an Overweight rating and $3 target. The Wall Street pros view is constructive, with the bulls focused on a novel VT ablation technology, potential FDA approval, and a large underpenetrated market. The main con is that this optimism is still forward-looking and is not yet backed by recent earnings or a confirmed technical uptrend.

Wall Street analysts forecast ADGM stock price to rise
1 Analyst Rating
Wall Street analysts forecast ADGM stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.700
sliders
Low
4
Averages
4
High
4
Current: 0.700
sliders
Low
4
Averages
4
High
4
Lucid Capital
Buy
initiated
$3
AI Analysis
2026-06-03
Reason
Lucid Capital
Price Target
$3
AI Analysis
2026-06-03
initiated
Buy
Reason
Lucid Capital initiated coverage of Adagio Medical with a Buy rating and $3 price target. The company created an ablation catheter that is purpose built for ventricular tachycardia, the analyst tells investors in a research note. The firm believes the \"stage is set\" for atrial fibrillation-like market acceleration off a base growing 5%-8% today, with Adagio \"as the clear victor.\"
Piper Sandler
Matt O'Brien
Overweight
initiated
$3
2026-04-14
Reason
Piper Sandler
Matt O'Brien
Price Target
$3
2026-04-14
initiated
Overweight
Reason
Piper Sandler analyst Matt O'Brien initiated coverage of Adagio Medical with an Overweight rating and $3 price target. The firm says the company has developed a novel ultra-low temperature cryoablation technology for the treatment of ventricular tachycardia. Piper expects the pivotal results from the FULCRUM-VT trial should support FDA approval and commercial launch in 2027. The "large, underpenetrated" $1.6B domestic opportunity provides "ample opportunity" for sales growth potential and could deliver upside to expectations, contends Piper.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for ADGM
Unlock Now

People Also Watch